In addition, previous work by our group has demonstrated that increased intracellular zinc release in breast cancer cells by active ZIP7, can also lead to decreased glycogen synthase kinase-3β (GSK3β) through inhibitory phosphorylation, further amplifying AKT driven cell survival [9]. This evidence concerns the gene AKT1 and breast carcinoma.